Mohamed Elrefaei

Mohamed Elrefaei, M.D., Ph.D. is a physician-scientist specializing in Laboratory Medicine and Pathology at Mayo Clinic in Jacksonville, Florida. His work focuses on the intersection of immunology, transplantation, and infectious diseases, with particular expertise in histocompatibility and immunogenetics.

Education:

• 2001: PhD in Immunology, Drexel University School of Medicine
• 1995: MD, Cairo University Medical School

Research Interests:

Dr. Elrefaei's research spans transplant immunology, histocompatibility, infectious diseases, autoimmunity, and allergy. His work bridges clinical practice with laboratory science, focusing on how immune responses affect transplant outcomes and disease progression. He has made significant contributions to understanding HLA typing, non-HLA antibodies in transplantation, and immune responses in various disease states.

Publication Trends:

Dr. Elrefaei's recent publications (2022-2025) show a strong focus on heart failure outcomes, lung transplantation, and advanced HLA typing techniques using next-generation sequencing. His work spans cardiology, pulmonary medicine, and immunogenetics, reflecting his interdisciplinary approach to medical research. A significant portion of his recent work examines the role of non-HLA antibodies in chronic lung allograft dysfunction and novel HLA allele identification.

Scientific Awards:

• 2008: International Clinical Research Fellowship award from NIH
• 2005: Ruth Kirschenstein-NRSA Fellowship award from NIH

Professional Activities:

Dr. Elrefaei maintains active membership in numerous professional societies including The Transplantation Society, American Society of Histocompatibility and Immunogenetics, International Society for Heart and Lung Transplantation, Clinical Immunology Society, American Society of Transplantation, Association of Medical Laboratory Immunologists, and American Association of Immunologists. His committee work includes serving on the Membership committee of the American Society of Histocompatibility and Immunogenetics (2018-2021) and the MCASOM Research subcommittee (2020-2021).

Certifications:

• 2013: Histocompatibility & Immunogenetics, American Board of Histocompatibility & Immunogenetics
• 2011: Medical Laboratory Immunology, American Board of Medical Laboratory Immunology